Deep South Dermatology — Daphne, Alabama

Deep South Dermatology is a clinical research site located in Daphne, Alabama, United States 36526.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Deep South Dermatology has participated in 2 clinical trials.

Therapeutic areas: Psoriasis, Chronic Plaque Psoriasis.

Sponsors: Genentech, Inc., AbbVie.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Daphne

Browse all research sites in Alabama · View every site in Daphne

• Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis
• Southern Cancer Center Pc
• Alliance for Multispecialty Research, LLC
• Southern Cancer Center
• Southern Cancer Center PC-Daphne
• Pfizer Investigational Site
• Alliance For Multispecialty Research - Daphne
• Research Site
• Southern Cancer Center, P.C.
• Southern Cancer Center (SCC) ( Site 8000)
• AMR Daphne, AL
• Amr Daphne

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Deep South Dermatology?

Deep South Dermatology has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Deep South Dermatology conducted?

Deep South Dermatology has 2 clinical trials on record. Their work covers Psoriasis, Chronic Plaque Psoriasis.

Is Deep South Dermatology accredited by Crixeo Clinical Trials?

Deep South Dermatology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Deep South Dermatology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.